Thailand no longer main draw for China tourists


THE country has lost its spot as the most popular cross-border destination for tourists from mainland China, according to a survey by HSBC Holdings Plc, as neighbouring Japan and South Korea moved up the list.

“Barring Hong Kong and Macau, Japan and Korea emerged as the top two preferred cross-border destinations, ” analyst Parash Jain wrote in a report.

“This reinforces our view that short-haul travel will recover earlier than long-haul international travel.”

The survey, conducted from Oct 28 to Nov 2, found that flight bookings were being made further in advance than they were pre-pandemic, which may reflect more demand for leisure travel than business.

Most survey respondents said they would need at least six months after quarantine restrictions were relaxed to become comfortable with international travel, and an effective vaccine was key to boosting confidence, Jain said.

The survey also showed that people were more confident about domestic travel due to China’s success in containing the virus. — Bloomberg

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3
   

Did you find this article insightful?

Yes
No

100% readers found this article insightful

Next In Aseanplus News

Philippines: Covid-19 total goes past 500,000; govt to receive free vaccines from China
India's COVID-19 vaccination drive hits bump due to app glitch
Thai PM says safety of people more important than rushing for vaccine; daily cases goes above 300
Japan: After one year of Covid-19; country still struggling to contain the pandemic
S.Korea: Covid-19 daily cases much lesser; social distancing rules eased
Chinese city reports coronavirus found on ice cream
China, Philippines agree to boost cooperation against pandemic
Vietnamese Communist Party meeting completes preparation for 13th National Congress
India: Covid-19 vaccination continues as govt reports 15,144 cases (10,557,985-total)
Pfizer reassures Europe over coronavirus vaccines as pandemic surges

Stories You'll Enjoy